We are live on
!
Find out more
ECM
EagleClaw Capital Management Portfolio holdings
AUM
$745M
1-Year Est. Return
23.99%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+23.99%
3 Year Est. Return
+104.02%
5 Year Est. Return
+140.24%
10 Year Est. Return
+617.44%
AUM
$198M
AUM Growth
+$21.5M
(+12%)
Cap. Flow
+$6.22M
Cap. Flow
% of AUM
3.14%
Top 10 Holdings %
Top 10 Hldgs %
32.46%
Holding
114
New
7
Increased
54
Reduced
22
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$593K |
| 2 |
Lowe's Companies
LOW
|
+$339K |
| 3 |
AET
Aetna Inc
AET
|
+$326K |
| 4 |
CoStar Group
CSGP
|
+$293K |
| 5 |
Deere & Co
DE
|
+$285K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$364K |
| 2 |
Baker Hughes
BKR
|
+$314K |
| 3 |
Nike
NKE
|
+$265K |
| 4 |
AGN
Allergan plc
AGN
|
+$204K |
| 5 |
Apple
AAPL
|
+$132K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.58% |
| 2 | Financials | 15.77% |
| 3 | Healthcare | 15.29% |
| 4 | Consumer Discretionary | 14.43% |
| 5 | Technology | 12.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
NVIDIA
NVDA
$5.17T
| $261K | 0.13% |
54,000
| – | – |
|
102
Teva Pharmaceutical Industries Limited
TEVA
$44.9B
| $258K | 0.13% |
13,550
-1,925
| -12% | -$29K |
|
103
Essential Utilities
WTRG
$11.7B
| $249K | 0.13% |
6,350
| – | – |
|
104
US Bancorp
USB
$93.1B
| $241K | 0.12% |
+4,500
| New | +$242K |
|
105
Philip Morris
PM
$299B
| $238K | 0.12% |
2,250
+150
| +7% | +$16K |
|
106
Automatic Data Processing
ADP
$109B
| $237K | 0.12% |
+2,025
| New | +$232K |
|
107
Amgen
AMGN
$203B
| $235K | 0.12% |
1,350
| – | – |
|
108
Union Pacific
UNP
$167B
| $229K | 0.12% |
+1,700
| New | +$205K |
|
109
Blackrock
BLK
$161B
| $220K | 0.11% |
+430
| New | +$209K |
|
110
Cummins
CMI
$72.6B
| $212K | 0.11% |
1,200
| – | – |
|
|
CRR
111
DELISTED
Carbo Ceramics Inc.
CRR
| $183K | 0.09% |
18,000
| – | – |
|
|
112
Baker Hughes
BKR
$55.9B
| – | – |
-8,600
| Closed | -$314K |
|
113
Clean Energy Fuels
CLNE
$375M
| – | – |
-11,000
| Closed | -$27K |
|
|
AGN
114
DELISTED
Allergan plc
AGN
| – | – |
-1,000
| Closed | -$204K |
|
Similar funds
AAM
IWP
CCME
HIG
CFS
HPM
PCM
BG
EagleClaw Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, EagleClaw Capital Management held 114 positions worth $198M, up 12% from $177M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
EagleClaw Capital Management deployed $6.22M of net new capital in Q4 2017, opening 7 new positions and adding to 54 existing holdings. Its largest new stake was Aetna Inc: 1,900 shares worth $342K.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $364K trimmed.
- EagleClaw Capital Management's largest Q4 2017 buy was Aetna Inc: 1,900 shares worth $342K.
- EagleClaw Capital Management added most to Berkshire Hathaway Class B in Q4 2017, an estimated $593K increase.
- EagleClaw Capital Management's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $364K.
- EagleClaw Capital Management fully exited Baker Hughes in Q4 2017, selling an estimated $314K.
- EagleClaw Capital Management's ten largest holdings make up 32% of its $198M portfolio in Q4 2017.
- EagleClaw Capital Management opened 7 new positions and closed 3 in Q4 2017.
- EagleClaw Capital Management's portfolio value rose 12% quarter-over-quarter to $198M.
Based on EagleClaw Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.